VeriMomalloferon-1 hamilelikte güvenli mi?
No harmonised CLP classification, no SCCS/CIR safety assessment or harmonised reproductive hazard found. Published literature describes alloferon-1 as a small immunomodulatory peptide with antiviral/anti‑inflammatory activity (animal and in vitro studies), but no reproductive or developmental toxicity or human pregnancy data were identified; topical cosmetic use therefore carries no documented reproductive hazard and exposure from typical topical use is expected to be negligible. Sources: PubMed studies and cosmetic ingredient listings.
Related ingredients
Frequently asked questions
- alloferon-1 hamilelikte güvenli mi?
- No harmonised CLP classification, no SCCS/CIR safety assessment or harmonised reproductive hazard found. Published literature describes alloferon-1 as a small immunomodulatory peptide with antiviral/anti‑inflammatory activity (animal and in vitro studies), but no reproductive or developmental toxicity or human pregnancy data were identified; topical cosmetic use therefore carries no documented reproductive hazard and exposure from typical topical use is expected to be negligible. Sources: PubMed studies and cosmetic ingredient listings.
- alloferon-1 emzirirken güvenli mi?
- No data (regulatory or peer‑reviewed) showing transfer into human milk or effects on nursing infants. No harmonised classification or authoritative cosmetic-safety body opinion (CIR/SCCS) found that flags a breastfeeding risk. Topical use would be expected to give negligible systemic exposure in adults.
- alloferon-1 bebek cildi için güvenli mi?
- No infant-specific hazard data were located. Because alloferon-1 is a 13‑amino‑acid peptide (~1.3 kDa) with published biological activity in vitro/in vivo after injection, complete non‑absorption cannot be assumed; therefore exposure (e) is increased by +1 for infant skin per your scoring rules (immature barrier/higher SA:BW). However, no studies of dermal absorption or infant effects were identified, and no regulatory flags were found.
- VeriMom alloferon-1 nasıl puanlıyor?
- VeriMom alloferon-1'yi EU CosIng, ECHA sınıflandırmaları ve PubMed çalışmalarına göre 100/100 (bilinen risk yok) olarak puanlar.
- Hamilelikte alloferon-1 yerine neler kullanılabilir?
- Benzer işlevli ve bilinen riski olmayan alternatifleri içeren listemize bakın.
Her etiketi 2 saniyede kontrol et
VeriMom'u ücretsiz indirin — herhangi bir ürünü tarayın ve hamilelik güvenlik puanını anında görün.
Tıbbi Sorumluluk Reddi
Bu bilgiler yalnızca eğitim amaçlıdır ve tıbbi tavsiye niteliği taşımaz. Güvenlik puanları kamuya açık verilere dayanmaktadır ve tüm riskleri yansıtmayabilir. Hamilelik veya emzirme döneminde herhangi bir ürünü kullanmadan önce her zaman sağlık uzmanınıza danışın.